The Food and Drug Administration grants emergency use authorization for Merck & Co.'s antiviral COVID-19 oral pill named Molnupiravir for at-risk individuuals. (Global News) COVID-19 pandemic in the United States, COVID-19 drug developmentCOVID-19 pandemic in North AmericaCOVID-19 pandemic link embed save